Business Wire

SYNAPS Dx DISCERN Provides First-to-Market Definitive Diagnostic Test for Alzheimer’s Disease, Supports Payer Treatment Decisions, Releases Paper Authored by Advisory Council

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, ...
Business Wire

Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis

PHILADELPHIA--(BUSINESS WIRE)--Proscia®, a leader in digital and computational pathology solutions, today announced that its Concentriq ® Dx platform has been certified under the new In Vitro ...
Nature

Human Diagnosis Project (Human Dx)

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...